Aacr Special Conference in Cancer Research: Cancer Biology-Informed Radioligand Therapy

The AACR Special Conference in Cancer Research: Cancer Biology-Informed Radioligand Therapy will convene at the Hilton San Diego Bayfront in San Diego, United States. This conference aims to gather experts from diverse fields including cancer biology, immunotherapy, and radioligand therapy (RLT) to discuss innovative approaches in treating cancer through RLT and synergistic methodologies with other treatment modalities. The event will focus on the significant advancements and collaborative efforts observed among academia, industry, and government in the realm of molecular imaging and RLT, which have shown potential to revolutionize cancer treatment strategies. A central theme of this conference is addressing the limitations in the field, particularly the need for a deeper understanding of the mechanisms by which therapeutic isotopes act on tumors, their microenvironments, and the immune response. Participants will engage in discussions that will cover various topics such as novel mechanisms of action for beta- and alpha-emitting isotopes, their interactions with tumors, and the immune system’s role in enhancing therapeutic efficacy. The conference seeks to foster a multi-disciplinary dialogue to bridge knowledge gaps across radiochemistry, instrumentation, nuclear physics, and radiation biology, facilitating the development of next-generation RLT therapies. Presentations will explore rational treatment approaches using novel isotopes and repurposed radioligand therapies, as well as innovative combinations with targeted therapies and external beam radiation. The insights gained from this gathering of experts will be vital for advancing RLT and providing new avenues for cancer treatment.